Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 (CALOR) 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy as Adjuvant for LOcally Recurrent (CALOR)

Chemotherapy vs. observation

DESIGN

Design 27-02

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Shari Gelber

Trial Coordinators
Holly Shaw

Data Managers
Karolyn Scott

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Other Pathology


News

18.12.2014:
New publications are available 

11.12.2014:
San Antonio Breast Cancer Symposium 2014: IBCSG Presents SOFT Results.

10.12.2014:
IBCSG and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast

All News

 
  Print